Upcoming Conferences: AAIC & NDD

July 22-26, Alliance representatives are attending the Alzheimer's Association International Con...
Read More

Dr. Kathleen Anne Welsh-Bohmer, PhD joins NeuroCog Trials as VP for Neurodegenerative Disorders

  Specializing in Alzheimer’s Disease (AD) and other neurological and age-related disord...
Read More

David Walling, PhD Quoted in Press Release Announcing FDA Approval of Alkermes' ARISTADA INITIO™ for Schizophrenia

Alkermes plc today announced that the U.S. Food and Drug Administration (FDA) has approved ARIST...
Read More